Meta Information

ID:mucuna-pruriens

Name:Mucuna Pruriens

Schema Version:1.5

Title

Mucuna Pruriens (Velvet Bean)

Alternate Names

• Velvet Bean
• Cowhage

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

15

High Cost:

30

Cost Type:

monthly

Description:

Standardized extracts (e.g., 15% L-DOPA) are widely available and affordable.

Summary

Mucuna Pruriens is a tropical legume whose seeds naturally contain high levels of levodopa (L-DOPA), the direct precursor to the neurotransmitter dopamine. Unlike pure synthetic L-DOPA, Mucuna contains other compounds that may enhance its bioavailability and reduce side effects. In the context of aging, dopamine levels naturally decline, leading to reduced motivation, motor control, and mood. Mucuna is used as a natural dopaminergic to restore youthful vitality and drive.

Purpose

To naturally elevate central dopamine levels, improving mood, motivation, and motor function.

Card Summary

A natural source of L-DOPA used to restore declining dopamine levels.

Drug Class

Drugs In Class

Empty Array

Impact

Score:

4.5

Justification:

Directly impacts neurotransmitter decline, a major quality-of-life issue in aging, though its effects are highly targeted.

Evidence

Grade:

B

Score:

7

Justification:

Clinically proven to contain active L-DOPA and studied heavily as an adjunct or alternative for Parkinson's disease.

Safety

Score:

3.5

Justification:

Carries more risk than typical adaptogens because it directly alters dopamine synthesis pathways.

Flags

• Long-term use can downregulate natural dopamine production; cycling is highly recommended (e.g., 5 days on, 2 days off).
• Contraindicated for individuals with schizophrenia or those taking MAO inhibitors.
• High doses can cause nausea, dyskinesia, or cardiovascular irregularities.

Verdict

A potent tool for addressing age-related dopaminergic decline, but requires careful cycling and respect for its pharmacological power.

Created

2026-05-06T18:22:00.000Z

Model

Gemini 3 Flash

Delivery

Route:

oral

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Used intermittently to combat anhedonia, low motivation, and the natural decline of dopamine associated with aging.

Typical Protocol

• Take 250-500 mg of an extract standardized to 15% L-DOPA early in the day, cycled to prevent receptor downregulation.